Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis
Journal of Bone and Mineral Research Feb 01, 2019
Beek KJ, et al. - In patients with ankylosing spondylitis (AS), researchers assessed the long term effects of TNF-inhibitors (TNFi) on bone mineral density (BMD) and the incidence of vertebral fractures (VFx). For this investigation, they involved consecutive patients with active AS with TNFi treatment duration up to 4 years with available DXA scans and spine X-rays. A total of 135 AS patients were included. Despite improving BMD and a well-known decrease in disease activity, investigators still found new VFx, an increase in the number and grade of VFx and radiographic progression during 4 years of TNFi treatment in long-term AS patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries